openPR Logo
Press release

Human Embryonic Stem Cells Market Size Forecasted To Achieve $2.02 Billion By 2029 With Steady Growth

05-28-2025 11:40 AM CET | Health & Medicine

Press release from: The Business Research Company

Human Embryonic Stem Cells

Human Embryonic Stem Cells

The Human Embryonic Stem Cells Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Human Embryonic Stem Cells Market Size and Projected Growth Rate?
The human embryonic stem cells market has seen rapid growth in recent years. It will grow from $1.24 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. Growth in this market is driven by increased funding and investment, regulatory approvals, greater public awareness, the emergence of regenerative medicine, and expanded clinical applications.

The human embryonic stem cells market is set to grow rapidly, reaching $2.02 billion by 2029 at a CAGR of 10.1%. This growth is driven by the rise in cell therapy production facilities, increasing demand for regenerative therapies, the prevalence of cardiac and malignant diseases, advancements in stem cell research, and awareness of stem cell therapeutic potential. Key trends include innovations in regenerative medicine, increased focus on personalized medicine, growing applications in drug discovery and toxicology, technological advancements, and expansion in biobanking.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16086

What Are the Major Segments in the Human Embryonic Stem Cells Market?
The human embryonic stem cells market covered in this report is segmented -

1) By Type: Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells
2) By Product: Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing
3) By Application: Research, Clinical Trials, Other Applications

Subsegments:
1) By Totipotent Stem Cells: Embryonic Totipotent Stem Cells, Induced Totipotent Stem Cells
2) By Pluripotent Stem Cells: Human Embryonic Stem Cells (hESCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cell Lines, Conditioned Pluripotent Stem Cells
3) By Unipotent Stem Cells: Somatic Stem Cells, Adult Stem Cells, Tissue-Specific Stem Cells

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16086&type=smp

What Are The Driving Human Embryonic Stem Cells Market Evolution?
Government funding for regenerative medicine is expected to drive the growth of the human embryonic stem cells market. Regenerative medicine is focused on repairing or regenerating tissues and organs, and human embryonic stem cells play a crucial role in developing potential therapies. The growing prevalence of chronic diseases and the promise of regenerative medicine have attracted government support for stem cell research. For example, Canada's government allocated $45 million to boost stem cell research in 2022, supporting the development of regenerative therapies. As funding continues, the human embryonic stem cell market is expected to expand.

Which Firms Dominate The Human Embryonic Stem Cells Market Segments?
Major companies operating in the human embryonic stem cells market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KgaA, Astellas Pharma Inc., Lonza Group, PerkinElmer Inc., R&D Systems, LifeCell, Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, CellGenix GmbH, PeproTech Inc., Lineage Cell Therapeutics Inc., BioTime, Asterias Biotherapeutics Inc., ESI BIO, STEMCELL Technologies Inc., TATAA Biocenter, Celgene Corporation

What Human Embryonic Stem Cells Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the human embryonic stem cell market are concentrating on broadening their horizons into various therapeutic applications like pluripotent stem cells for Parkinson's disease, with an aim to gain a competitive advantage in the market. The role of pluripotent stem cells in Parkinson's disease treatment is to create dopaminergic neurons with the goal of replacing lost dopamine-producing neurons and restoring motor functions. Bayer AG, a pharmaceutical and biotechnology company based in Germany, illustrated this in October 2023 when they launched their inaugural Cell Therapy Manufacturing Facility in California. They made an investment of $250 million to manufacture cell and gene therapies on a global scale. Initially, this facility will focus on generating bemdaneprocel from pluripotent stem cells (PSC) for BlueRock Therapeutics' Parkinson's disease treatment. The facility is equipped with completely electric production to fulfil the industrial manufacturing capacity requirements for regenerative medicines.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Which Is The Largest Region In The Human Embryonic Stem Cells Market?
North America was the largest region in the human embryonic stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human embryonic stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Human Embryonic Stem Cells Market?
2. What is the CAGR expected in the Human Embryonic Stem Cells Market?
3. What Are the Key Innovations Transforming the Human Embryonic Stem Cells Industry?
4. Which Region Is Leading the Human Embryonic Stem Cells Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Embryonic Stem Cells Market Size Forecasted To Achieve $2.02 Billion By 2029 With Steady Growth here

News-ID: 4040066 • Views:

More Releases from The Business Research Company

Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Leading Companies
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector. Projected Growth and Market Size of the Nano Antibodies Market The nano antibodies market is anticipated
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody Market Landscape
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward. Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Leading Companies
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector. Projected Growth and Market Size of the Nano Antibodies Market The nano antibodies market is anticipated
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody Market Landscape
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward. Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody

All 5 Releases


More Releases for Cell

Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting. Download Full PDF Sample Copy
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging